Dave Fornell, DAIC Editor

Dave Fornell, Editor DAIC

Blog | Dave Fornell, DAIC Editor | February 07, 2012

The da Vinci Robot is a Case of Seeing is Believing

Being a child of the late 1970s and 1980s, I was a big Star Wars fan. Somewhere in my basement I still have the action figure of the multi-armed surgical robot that repaired Luke Skywalker’s severed hand at the end of the movie the “Empire Strikes Back.” The resemblance of today’s multi-armed de Vinci surgical robot was not lost on those from the Star Wars generation.

However, as much of a fan I am of science fiction and cool new technology, I am also realist, especially in regards to healthcare, where cost, efficacy and patient outcomes matter. I had my doubts about the da Vinci robotic system and its ability to out-perform the tactile feel of an experienced surgeon’s hand.  At first glance, the da Vinci appears cumbersome, intimidating and as if it would be more of a barrier between the patient and the surgeon during procedures.

Despite appearances, I continued to see a regular flow of positive reports about the system from various specialties, including cardiology. But, I remained skeptical because most of these reports came from hospital public relations releases, touting how their facility had the latest and greatest technology to attract new patients.

I am a hands-on sort of guy and I prefer to write about technologies I have not seen in person, especially those I have seen in action. I’m not a physician, but there are universal truths concerning all technology regarding ease of use. If a technology is complicated to use, temperamental or requires a large amount of time for training and use, it will not become a mainstream tool. The KISS (keep it simple stupid) axiom applies even in medicine.   

At the 2010 American College of Cardiology (ACC) meeting I had the opportunity to try out the ability of the da Vinci system in the Philips Healthcare hybrid OR pavilion. Seeing is definitely believing and end-users who say the system sells itself appear to be accurate. The system allows you to sit down and get an up-close, magnified view of tiny objects. The view from the da Vinci cockpit allows you to feel as if the field of view is normal, when it is actually closer to that of the watchmaker or jeweler’s world.

Rather than hindering movement, da Vinci enhances it. My hands are not the steadiest and replacing the tiny screw in my glasses can sometimes be a challenge, but with the da Vinci, hand movements are smoothed, more incremental and controlled as they translate to the tiny clips at the end of da Vinci’s arms.

The demo system at ACC had tiny, sharply pointed rubber cones about a quarter of an inch in diameter and about one inch high. Small rubber bands, like those used to keep tension on orthodontic braces, could easily be picked up, stretched and handed from one arm to another and then placed accurately over a cone, pulled off and placed on another with ease.

In the system cockpit the task looks easy and the controls very intuitive. But the tiny nature of the field of view and the objects being precisely manipulated was extremely impressive.

As with any technology, there is certainly a learning curve, epecially for physicians who have learned and practiced doing procedures one way for years. End-users of the da Vinci, including those I spoke with recently at Mayo Clinic in Rochester, Minn., say surgeons need to re-learn how they perform procedures using the robot. However, the technology has enabled them to perform minimally invasive procedures that otherwise would be very difficult or impossible.

As a demonstration of the da Vinci’s abilities for both the physician and the layman, I found the following three YouTube videos. In two, the operators create an origami swan that is smaller than the size of a penny. The third videos shows an operator precisiely peeling a grape. The videos illustrate the system’s fantastic, undistorted, magnified field of view.

Watch the origami videos at: www.youtube.com/watch?v=x9Bjs99A0k0  and www.youtube.com/watch?feature=endscreen&v=pxInFn047js&NR=1

Peeling a grape: www.youtube.com/watch?feature=endscreen&v=LzYmDbISnzY&NR=1

Related Content

Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery| February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders| February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...
heart team, hybird OR, structural heart team

The heart team approach was first used on a large scale in the CoreValve and Sapien TAVR trials and helped lead to excellent outcomes in high-risk patients.

Feature | Hybrid OR| February 15, 2017 | Dave Fornell
In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve p
 Intra-atrial shunt device (IASD) to lower left atrial pressure by creating a small left atrial to right atrial shunt.  Abraham said these devices are in early stage development with small studies to show proof of concept and demonstrate safety.

The Corvia Intra-atrial shunt device (IASD) lowers left atrial pressure by creating a small left atrial to right atrial shunt. Preliminary clinical studies have shown promise for these types of devices to improve HFpEF patient outcomes.

Feature | Heart Failure| February 10, 2017 | Dave Fornell
In the past few years there have been a number of device therapies developed to treat heart failure (HF).
Xarelto, rivaroxaban, COMPASS study, ends early,
News | Antiplatelet and Anticoagulation Therapies| February 09, 2017
February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopp
Sponsored Content | Videos | Heart Failure| February 06, 2017
This video demonstrates how to implant the Revivent TC System to reduce the volume of the left ventricle (LV) in hear
Amplatzer PFO Occluder, St. Jude Medical, Baylor Heart and Vascular Services, Fort Worth, Texas, first patients
News | Structural Heart Occluders| February 01, 2017
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer...
Edwards Lifesciences, completes acquisition, Valtech Cardio
News | Heart Valve Technology| January 25, 2017
Edwards Lifesciences Corp. announced that it has closed its acquisition of Valtech Cardio Ltd., developer of the...
congenital heart disease, CHSD, Society of Thoracic Surgeons, public reporting, parent preferences
News | Congenital Heart| January 25, 2017
Survival statistics, surgeon-specific experience and complication rates are the types of information most wanted by...
SAVR, surgical aortic valve replacement, elderly patients, aortic stenosis, Society of Thoracic Surgeons, clinical study
News | Structural Heart| January 25, 2017
Elderly patients with aortic stenosis (AS) and medium surgical risk experienced better than expected results after...
Overlay Init